Doç. Dr. Kadriye Bir Yücel

Efficacy of Capecitabine and Temozolomide Regimen in Neuroendocrine Tumors: Data From the Turkish Oncology Group

The Oncologist, 2023

DOI 10.1093/oncolo/oyad257 PMID 37676712 8 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex

443P Efficacy and safety of CDK 4/6 inhibitors in patients with bone marrow-involved metastatic breast cancer

Annals of Oncology, 2023

DOI 10.1016/j.annonc.2023.09.619 Frei zugänglicher VolltextQuelle: OpenAlex

Nivolumab-ipilimumab combination therapy-induced seronegative encephalitis; rapid response to steroid plus intravenous immunoglobulin (IVIG) treatment

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2023

DOI 10.1177/10781552221118529 PMID 35938177 5 Zitationen (Europe PMC) Quelle: Europe PMC

Survival Outcomes of Non-squamous Cell Carcinoma and Rare Squamous Cell Carcinoma Variants of the Larynx

Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India, 2023

DOI 10.1007/s12070-023-03934-8 PMID 37974887 1 Zitation (Europe PMC) Frei zugänglicher VolltextQuelle: Europe PMC

Retrospective Analysis of Real-Life Data Evaluating the Optimal Time Between Gastrectomy and Adjuvant Chemotherapy in Resected Gastric Cancer

Journal of gastrointestinal cancer, 2023

DOI 10.1007/s12029-023-00916-5 PMID 36821038 1 Zitation (Europe PMC) Quelle: Europe PMC

Effects of Sarcopenia, Myosteatosis, and the Prognostic Nutritional Index on Survival in Stage 2 and 3 Gastric Cancer Patients

Nutrition and cancer, 2023

DOI 10.1080/01635581.2022.2121845 PMID 36093734 7 Zitationen (Europe PMC) Quelle: Europe PMC

Greater financial toxicity correlates with increased psychological distress and lower quality of life among Turkish cancer patients

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2023

DOI 10.1007/s00520-023-07586-w PMID 36700998 22 Zitationen (Europe PMC) Quelle: Europe PMC

2066P Evaluation of the quality and reliability of ChatGPT and Perplexity's responses about rectal cancer

Annals of Oncology, 2023

DOI 10.1016/j.annonc.2023.09.848 1 Zitation (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

Prognostic Significance of the Gustave-Roussy Immune Score in Colon Cancer Patients Treated with Adjuvant CAPEOX Regimen

Eurasian Journal of Medical Investigation, 2023

DOI 10.14744/ejmi.2023.93298 Frei zugänglicher VolltextQuelle: OpenAlex

429P The impact of HER2 status on the efficacy of CDK 4/6 inhibitors: A multicenter study

Annals of Oncology, 2023

DOI 10.1016/j.annonc.2023.09.605 Frei zugänglicher VolltextQuelle: OpenAlex

2162P Can artificial intelligence provide accurate and reliable answers to cancer patients' questions? Comparison of chatbots based on the ESMO Patient Guide about cancer pain

Annals of Oncology, 2023

DOI 10.1016/j.annonc.2023.09.944 Frei zugänglicher VolltextQuelle: OpenAlex

The relationship between systemic immune inflammation index and survival in patients with metastatic renal cell carcinomatreated withtyrosine kinase inhibitors

Scientific Reports, 2022

DOI 10.1038/s41598-022-20056-3 PMID 36192500 15 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID

ROAR trial: which treatment is effective after progression?

The Lancet Oncology, 2022

DOI 10.1016/s1470-2045(21)00754-3 PMID 35240094 Quelle: OpenAlex

Neutrophil–lymphocyte ratio as a prognostic factor for survival in patients with advanced renal cell carcinoma (Turkish Oncology Group Study)

Journal of Oncology Pharmacy Practice, 2020

DOI 10.1177/1078155219900908 PMID 32054412 9 Zitationen (Europe PMC) Quelle: OpenAlex

Akciğer Kanserinde Paraneoplastik Sendromlar

2020

Quelle: OpenAlex

The relationship between prognostic nutritional index and treatment response in patients with metastatic renal cell cancer

Journal of Oncology Pharmacy Practice, 2019

DOI 10.1177/1078155219883004 PMID 31653193 17 Zitationen (Europe PMC) Quelle: OpenAlex

EP1034 Comparing the efficiency of interval debulking surgery after neoadjuvant chemotherapy with primary debulking surgery in patients with stage 3 and 4 ovarian carcinoma: multicenter real world data

International Journal of Gynecological Cancer, 2019

DOI 10.1136/ijgc-2019-esgo.1078 Frei zugänglicher VolltextQuelle: OpenAlex